siRNA, Anti-SLC38A4, 2'-MOE-modified(CAT#: SIRGT43522WQ-2MOE)

The product SIRGT43522WQ-2MOE is a type of small interfering RNA (siRNA) that targets SLC38A4 gene and regulates the expression of gene. The siRNA interferes with the expression of SLC38A4 gene with complementary nucleotide sequences by degrading mRNA after transcription, preventing translation. The siRNA is designed with 2'-O-methoxyethyl (2'-MOE) modification to provide increased stability, increased specificity and reduced immunogenicity. It has potential applications in RNA interference (RNAi) and gene therapy development.

Specifications
Modification 2'-O-methoxyethyl (2'-MOE)
Scale 20/50/100/200 nmole
NCBI RefSeq NM_001143824.1
Alternative Names ATA3; NAT3; PAAT; SNAT4
Related Diseases Loeys-Dietz Syndrome
Purification HPLC
Target Gene
Gene ID 55089
Uniprot ID Q969I6

Related Products